Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chromosomal Instability as an Indicator for the Treatment of Progressive Mucosal Lesions of the Oral Cavity.

NCT02238574 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02238574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02238574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chromosomal Instability as an Indicator for the Treatment of Progressive Mucosal Lesions of the Oral Cavity.
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Withdrawn
Start date
Not reported
Completion date
December 31, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chromosomal instability, fluorescence in situ hybridization, loss of heterozygostiy, low grade dysplasia oral cavity